Form 4: Aveanna Healthcare Holdings Insider Sells Shares Under 10b5-1 Plan

Paul R. Vigano, a director indirectly associated with major shareholders of Aveanna Healthcare Holdings, reports sales of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Paul R. Vigano, indirectly associated with significant Aveanna Healthcare Holdings shareholders, reported the sale of common stock.
• The sales occurred on April 1st and 2nd, 2025, at a weighted average price of $5.63 per share.
• The transactions were executed under a pre-existing Rule 10b5-1 trading plan adopted on December 13, 2024.
• The shares were sold by various entities including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, and JHW Iliad Holdings II LLC.
• Vigano disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to insider trading. The sentiment is neutral as it simply reports transactions under a pre-arranged plan.

Industry Context

Insider sales are a common occurrence, but the use of a 10b5-1 plan suggests the sales were pre-planned and not based on current inside information. Monitoring insider activity can provide insights into management's perspective on the company's valuation and future prospects.

Stakeholder Impact

• Shareholders may interpret insider sales as a lack of confidence in the company, although sales under a 10b5-1 plan are generally less concerning.

Key Dates

Keywords

Form 4, insider trading, Rule 10b5-1, Aveanna Healthcare Holdings, AVAH, stock sale, Paul R. Vigano, J.H. Whitney, PSA Healthcare, JHW Iliad